On April 24, 2015, Steven A. Shallcross, the Chief Financial Officer of Nuo Therapeutics, Inc. informed to the Company of his resignation, effective as of May 24, 2015. David E. Jorden will be relinquishing his role as Executive Chairman of the Board ("Board") and will transition to Acting Chief Financial Officer of the Company, a role which he will officially assume effective as of May 25, 2015. Effective May 1, 2015, Joseph Del Guercio an existing member of the Board, has been appointed Acting Chairman of the Board.

Mr. Del Guercio has served as a director since February 2012 and has been a Managing Director at CNF Investments LLC (CNF) since November 2004. He serves as a Director of several CNF portfolio companies, including Verax Biomedical, Flyby Media, AnyPresence, and PlaceCast.